1. McCarty CA, Taylor HR. Recent developments in vision research : light damage in cataract.
Invest Ophthalmol Vis Sci 1996;37:1720-1723.
2. Norren DV, Vos JJ. Spectral transmission of the human ocular media.
Vision Res 1974;14:1237-1244.
3. Margrain TH, Boulton M, Marshall J, Sliney DH. Do blue light filters confer protection against age-related macular degeneration.
Prog Retin Eye Res 2004;23:523-531.
4. Patton WP, Chakravarthy U, Davies RJ, Archer DB. Comet assay of UV-induced DNA damage in retinal pigment epithelial cells.
Invest Ophthalmol Vis Sci 1999;40:3268-3275.
5. Mainster MA. The spectra, classification, and rationale of ultraviolet-protective intraocular lenses.
Am J Ophthalmol 1986;102:727-732.
6. Sujak A, Gbrielska J, Grudzinski W, et al. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: The structural aspects.
Arch Biochem Biophys 1997;371:301-307.
7. Sujak A, Okulski W, Gruszecki WI. Organisation of xanthophyll pigment lutein and zeaxanthin in lipid membranes formed with dipalmitoylphosphatidylcholine.
Biochim Biophys Acta 2000;1509:255-263.
8. Yu HG, Choe GS, Heo JW, et al. Oxidative Damage induced by UV in Cultured Retinal Pigment Epithelial Cells. J korean Ophthal Society 2003;44:2890-2895.
9. Sadun AC, Sadun AA, Sadun LA. Solar retinopathy. A biophysical analysis.
Arch Ophthalmol 1984;102:1510-1512.
10. Young RW. Solar radiation and age-related macular degeneration.
Surv Ophthalmol 1988;32:252-269.
11. Van Kuijk FJ. Effect of ultraviolet light on the eye: role of protective glasses.
Environ Health Perspect 1991;96:177-184.
12. Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats.
Invest Ophthalmol 1966;5:450-473.
13. Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration.
Surv Ophthalmol 2000;45:115-134.
14. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss.
Arch Ophthalmol 2001;119:1417-1436.
15. Antioxidant status and neovascular age-related macular degeneration.
Arch Ophthalmol 1993;111:104-109.
16. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration.
JAMA 1995;272:1413-1420.
17. Hanneken A, Lin FF, Johnson J, Maher P. Flavonoids Protect Human Retinal Pigment Epithelial Cells from Oxidative-Stress-Induced Death.
Invest Ophthalmol Vis Sci 2006;47:3164-3177.
18. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer.
Pharmacol Rev 2000;52:673-751.
19. Wang YC, Bachrach U. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Amino Acids 2002;22:131-143.
20. Kimura M, Umegaki K, Kasuya Y, et al. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans.
Eur J Clin Nutr 2002;56:1186-1193.
21. Buttemeyer R, Philipp AW, Schlenzka L, et al. Epigallocatechin gallate can significantly decrease free oxygen radicals in the reperfusion injury in vivo.
Transplant Proc 2003;35:3116-3120.
22. Morley N, Clifford T, Salter L, et al. The green tea polyphenol (-)-epigallocatechin gallate and green tea can protect human cellular DNA from ultraviolet and visible radiation-induced damage.
Photodermatol Photoimmunol Photomed 2005;21:15-22.
23. Nagai K, Jiang MH, Hada J, et al. (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant.
Brain Res 2002;956:319-322.
24. Xie D, Liu G, Zhu G, et al. (-)-Epigallocatechin-3-gallate protects cultured spiral ganglion cells from H
2O
2-induced oxidizing damage.
Acta Otolaryngol 2004;124:464-470.
25. Mandel S, Weinreb O, Amit T, Youdim MB. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-pigallocatechin-3-gallate : implications for neurodegenerative diseases.
J Neurochem 2004;88:1555-1569.
26. Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain.
Phytomedicine 2002;9:232-238.
27. Yokozawa T, Nakagawa T, Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats.
J Agric Food Chem 2002;50:3549-3552.
28. Negishi H, Xu JW, Ikeda K, et al. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats.
J Nutr 2004;134:38-42.
29. Sutherland BA, Rahman RMA, Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.
J Nutr Biochem 2006;17:291-306.
30. Chung JH, Han JH, Hwang EJ, et al. Dual mechanisms of green tea extract (EGCG) induced cell survival in human epidermal keratinocytes.
FASEB J 2003;17:1913-1915.
31. Zhang B, Osborne NN. Oxidative-induced retinal degeneration is attenuated by Epigallocatechin gallate.
Brain Res 2006;1124:176-187.
32. Pietta PG. Flavonoids as antioxidants.
J Nat Prod 2000;63:1035-1042.
33. Weiter JJ. In: Miller D, Phototoxic changes in the retina.
Clinical Light Damage to the Eye. 1987. New York: Springer; p. 79-125.
34. Bynoe LA, Gottsch JD, Pou S, Rosea GM. Light-dependent generation of superoxide from human erythrocytes.
Photochem Photobiol 1992;56(3):353-356.
35. Kielbassa C, Roza L, Epe B. Wavelength dependence of oxidative DNA damage induced by UV and visible light.
Carcinogenesis 1997;18(4):811-816.
36. Osborne NN, Casson RJ, Wood JP, et al. Retinal ischemia: mechanisms of damage and potential therapeutic strategies.
Prog Retin Eye Res 2004;23:91-147.
37. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma.
Mutat Res 2006;612:105-114.
38. Tezel G. Oxidative stress in glaucomatous neurodegeneration : Mechanisms and consequences.
Prog Retin Eye Res 2006;25:490-513.
39. Osborne NN, Ugate M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
Surv Ophthalmol 1999;43:S102-S128.
40. Flammer J, Orgul S. Optic nerve blood-flow abnormalities in glaucoma.
Prog Retin Eye Res 1998;17:267-289.
41. Chen JH, Tipoe GL, Liong EC, et al. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants.
Am J Clin Nutr 2004;80:742-751.
42. Tedeschi E, Suzuki H, Menegazzi M. Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition.
Ann N Y Acad Sci 2002;973:435-437.
43. Lorenz M, Wessler S, Follmann E, et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation.
J Biol Chem 2004;279:6190-6195.
44. Delaney Y, Walshe TE, O'Brien C. Vasospasm in glaucoma: Clinical and laboratory aspects.
Optom Vis Sci 2006;83:406-414.